Big Pharma Split Corp.

TSX:PRM.TO

13.15 (CAD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2024 Q22023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Revenue 1.1130.9910.362.205-0.1993.0271.5241.8011.8011.5351.5351.2461.246-0.046-0.0460.4010.4011.7581.758-0.558-0.5582.1492.1491.0441.0440.8080.1020.1020.102
Cost of Revenue 0.1620.14900.1600.21700000000000000.060.060.0600.0690.0690.069000
Gross Profit 0.9510.8420.362.045-0.1992.811.5241.8011.8011.5351.5351.2461.246-0.046-0.0460.4010.4011.7581.758-0.618-0.6182.092.1490.9750.9750.7390.1020.1020.102
Gross Profit Ratio 0.8540.8510.92810.92811111111111111.1071.1070.97210.9340.9340.915111
Reseach & Development Expenses 00000000000000000000000000000
General & Administrative Expenses 00.1520.1520.1380.1380.1920.1920.1530.1530.2150.2150.2010.2010.0920.0920.1220.1220.1260.1260.1370.1370.1480.1480.1550.1550.080.0190.0190.019
Selling & Marketing Expenses 00000000000000000000.0270.0270.0270-0.047-0.047-0.047-0.018-0.018-0.018
SG&A 00.1520.1520.1380.1380.1920.1920.1530.1530.2150.2150.2010.2010.0920.0920.1220.1220.1260.1260.1370.1370.1480.1480.1550.1550.0330.0020.0020.002
Other Expenses 0.551-0.6630-2.3640-2.09800000000000000000000000
Operating Expenses -0.5510.6630.272.3640.042.0981.1680.5840.5830.5620.5620.230.230.5590.5590.7810.7810.0430.0430.4160.4160.8580.8580.9450.9450.0330.0020.0020.002
Operating Income 1.5020.1790.185-0.319-0.3660.7111.3071.5751.5751.2951.2951.0081.008-0.158-0.1580.2510.2511.6121.612-0.73-0.731.9771.9770.8520.8521.4870.0810.0810.081
Operating Income Ratio 1.3490.1810.514-0.1451.8390.2350.8570.8750.8750.8430.8430.810.813.4133.4130.6250.6250.9170.9171.3081.3080.920.920.8160.8161.8410.7940.7940.794
Total Other Income Expenses Net -0.263-0.257-0.224-0.2480.083-0.976-1.141-0.545-0.545-0.5-0.51.6120.3020.5540.554-1.26-0.756-0.031-0.0310.4390.439-0.854-0.854-0.923-0.923-0.792000
Income Before Tax 1.24-0.078-0.039-0.567-0.2840.330.1651.031.030.7940.7941.311.310.3960.396-0.505-0.5051.5821.582-0.292-0.2921.1231.123-0.071-0.0710.6950.0810.0810.081
Income Before Tax Ratio 1.113-0.079-0.109-0.2571.4240.1090.1080.5720.5720.5170.5171.0521.052-8.573-8.573-1.258-1.2580.90.90.5230.5230.5230.523-0.068-0.0680.860.7940.7940.794
Income Tax Expense 0-0.224-0.2240.0830.083-1.141-1.141-0.545-0.545-0.5-0.50.3020.3020.5540.554-0.756-0.756-0.031-0.031-0.336-0.336-0.336-0.8540.7920.7920.792000
Net Income 1.24-0.078-0.039-0.567-0.2840.330.1651.031.030.7940.7941.311.310.3960.396-0.505-0.5051.5821.582-0.292-0.2921.1231.123-0.071-0.071-0.0970.0810.0810.081
Net Income Ratio 1.113-0.079-0.109-0.2571.4240.1090.1080.5720.5720.5170.5171.0521.052-8.573-8.573-1.258-1.2580.90.90.5230.5230.5230.523-0.068-0.068-0.120.7940.7940.794
EPS 0.99-0.067-0.033-0.45-0.230.260.110.680.680.570.571.11.10.420.42-0.48-0.481.51.5-0.22-0.220.830.83-0.052-0.052-0.0720.0590.0590.059
EPS Diluted 0.99-0.067-0.033-0.45-0.230.260.110.680.680.570.571.11.10.420.42-0.48-0.481.51.5-0.22-0.220.830.83-0.052-0.052-0.0720.0590.0590.059
EBITDA 1.5020.181-0.2240.0830.0830.711-1.141-0.545-0.545-0.5-0.50.3020.3021.0260.554-1.01-0.756-0.031-0.0310.4390.439-0.854-0.854-0.923-0.9230.6950.0810.0810.081
EBITDA Ratio 1.3490.181-0.622-0.145-0.4150.235-0.749-0.303-0.303-0.326-0.3260.2420.242-11.986-11.986-1.883-1.883-0.017-0.017-0.786-0.786-0.397-0.397-0.884-0.8840.860.7940.7940.794